Perivis

Summary of earnings call for Coromandel International Ltd published on 01 Aug, 2025

Coromandel International Limited
Q1 FY26
Call date · July 25, 2025

1 · Management Commentary

Key Positives

Key Negatives

Forward Guidance

2 · Q&A Highlights

Q 1 (Composite): What are the plans for specialty fertilizer manufacturing in India and rare earth mineral extraction?
A (Management):
• Evaluating investments to create capacity for key specialty fertilizer raw materials for captive use and exports; no current plans for rare earth mineral extraction.

Q 2 (Composite): Outlook on DAP supply, global capacity, and margin sustainability given raw material price trends?
A (Management):
• Confident Middle East supply will offset China shortfall; global capacity expansions underway; expect DAP prices to soften post-Rabi; aim to sustain INR5,000/MT EBITDA margin.

Q 3 (Composite): Update on BMCC output, scaling plans, and revenue contribution?
A (Management):
• FY26 output expected at 300,000–400,000 tons, aiming to double in 2 years; FY revenue run-rate INR350–400 crores.

Q 4 (Composite): Impact of backward integration and commodity price volatility on margins?
A (Management):
• Backward integration provides some insulation, but multiple factors (raw material sourcing, productivity, pricing) affect margins; digital initiatives and procurement efficiencies help mitigate volatility.

Q 5 (Composite): Status and strategic rationale for NACL acquisition and integration?
A (Management):
• Competition Commission approval received, awaiting SEBI clearance; integration to leverage complementary portfolios, expand branded formulations, and explore CRAMS; NACL to run as a subsidiary post-acquisition.

Q 6 (Composite): Capex funding plans and debt outlook?
A (Management):
• Capex to be funded from internal accruals and, if needed, long-term debt at favorable rates; open to debt for strategic investments.

Q 7 (Composite): Expansion strategy in North/Central India and plans for new plants?
A (Management):
• Expanding market presence using Kakinada capacity; no immediate plans for new plants in North; leveraging government freight reimbursement for competitiveness.

Q 8 (Composite): Crop Protection and Bio segment growth, export/domestic mix, and future outlook?
A (Management):
• Crop Protection: 40% exports, 60% domestic; domestic formulations volume up 33%, exports up 20%, Bio doubled; strong growth momentum expected to continue.

3 · Other Key Numbers



Note: This is an AI generated summary of the earnings call. There may be inaccuracies in the summary. Please refer to the original transcript before making investment decisions.